The Canadian Network for Mood and Anxiety Treatments guidelines for the treatment of bipolar disorder outline a step-wise approach to helping patients with acute mania, including detailing which pharmacotherapies should be attempted as a first-line therapy, before moving on to second- and third-line therapies.1

  • Hierarchy of first-line monotherapies for acute mania: lithium, quetiapine, valproate, asenapine, aripiprazole, paliperidone, risperidone, cariprazine.
  • Hierarchy of first-line combination therapies for acute mania: lithium or valproate with quetiapine, aripiprazole, risperidone, or asenapine.
  • Hierarchy of second-line combination therapies for acute mania: olanzapine, carbamazepine, lithium or valproate with olanzapine, lithium with valproate, ziprasidone, haloperidol, electroconvulsive therapy.

Reference:
1. Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord 2018; 20 (2): 97–170.